Cristina Fillat
Barcelona, CT 08036, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 57 publications
Position-specific polymeric-coated oncolytic adenovirus improves anti-tumor efficacy and evades neutralizing antibodies in pancreatic cancer models.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: March 17, 2026
Folate- and aCD47-functionalized lipid nanoparticles efficiently deliver mRNA and remodel pancreatic tumor microenvironment.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: October 17, 2025
Antagonistic SMAD2/3 control of TIMP-1, VEGF-A, and hypoxia signaling in myofibroblasts shapes histotype-specific angiogenesis in lung cancer.
Journal: Cell death & disease
Published: September 29, 2025
Therapeutic AASS inhibition by AAV-miRNA rescues glutaric aciduria type I severe phenotype in mice.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: January 08, 2025
KPC pancreatic cancer cells are a novel immunocompetent murine model supporting human adenovirus replication and tumor oncolysis.
Journal: Molecular therapy. Oncology
Published: August 01, 2024
Aronia Berry Extract Modulates MYD88/NF-kB/P-Glycoprotein Axis to Overcome Gemcitabine Resistance in Pancreatic Cancer.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: June 09, 2024
ARI0003: Co-transduced CD19/BCMA dual-targeting CAR-T cells for the treatment of non-Hodgkin lymphoma.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: April 09, 2024
Systemic delivery of AAV-GCDH ameliorates HLD-induced phenotype in a glutaric aciduria type I mouse model.
Journal: Molecular therapy. Methods & clinical development
Published: October 11, 2023
Modeling Glutaric Aciduria Type I in human neuroblastoma cells recapitulates neuronal damage that can be rescued by gene replacement.
Journal: Gene therapy
Published: May 12, 2023
Andrographis Reverses Gemcitabine Resistance through Regulation of ERBB3 and Calcium Signaling Pathway in Pancreatic Ductal Adenocarcinoma.
Journal: Biomedicines
Published: November 23, 2022
Berberine Overcomes Gemcitabine-Associated Chemoresistance through Regulation of Rap1/PI3K-Akt Signaling in Pancreatic Ductal Adenocarcinoma.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: August 28, 2022
Last Updated: 09/26/2026